NASDAQ:FBIO
Fortress Biotech Stock News
$1.75
-0.0500 (-2.78%)
At Close: May 03, 2024
FBIO Stock: Why It Increased Today
12:38pm, Wednesday, 29'th Sep 2021
The stock price of Fortress Biotech (NASDAQ: FBIO) increased by over 4% today. This is why it happened.
Option exercise triggers upfront payment of approximately $150 million to Caelum shareholders, of which approximately $64 million is payable to Fortress Biotech 1
Fortress Biotech to Participate in Three September 2021 Investor Conferences
08:30am, Thursday, 09'th Sep 2021
NEW YORK, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring, developing and commercializing or mon
Fortress Biotech (FBIO) Reports Q2 Loss, Tops Revenue Estimates
06:18pm, Monday, 16'th Aug 2021
Fortress Biotech (FBIO) delivered earnings and revenue surprises of 71.43% and 29.11%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Fortress Biotech Reports Record Second Quarter 2021 Financial Results and Recent Corporate Highlights
04:01pm, Monday, 16'th Aug 2021
Net revenue for second quarter of 2021 increased 89% year-over-year to $17.8 million, a quarterly record
Why Fortress Biotech Stock Is Sinking Today
12:27pm, Monday, 14'th Jun 2021
The FDA refused to approve IV tramadol for the second time.
Best Penny Stocks To Buy? 4 To Watch This Week With Potential Catalysts
12:16pm, Sunday, 13'th Jun 2021
Penny stocks to watch with upcoming event dates to keep in mind this week The post Best Penny Stocks To Buy? 4 To Watch This Week With Potential Catalysts appeared first on Penny Stocks to Buy, Picks,
Biotech Penny Stocks To Watch For June 2021
10:24am, Sunday, 06'th Jun 2021
These penny stocks are expecting to release key information this month. The post Biotech Penny Stocks To Watch For June 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyS
The following article is sponsored by the clinical communications unit of Redington, Inc. The information contained in this article in no way represents investment advice or opinion on the part of Ben
Fortress Biotech to Participate in Three June 2021 Virtual Investor Conferences
08:30am, Tuesday, 01'st Jun 2021
NEW YORK, June 01, 2021 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring, developing and commercializing or mone
Fortress Biotech Reports First Quarter 2021 Financial Results and Recent Corporate Highlights
04:00pm, Sunday, 16'th May 2021
Rolling NDA submission for CUTX-101 for the treatment of Menkes disease is expected to begin in the second half of 2021
4 Biotech Stocks Set to Outpace Q1 Earnings Estimates
12:10pm, Thursday, 13'th May 2021
Let us take a look at some drug/biotech stocks that are poised to beat on first-quarter earnings.
Fortress Biotech Announces Exclusive License Agreement With Fuji Yakuhin to Develop Dotinurad in North America and Europe
06:30am, Monday, 10'th May 2021
Agreement signed with Fuji Yakuhin to develop Dotinurad, a potential best-in-class urate transporter (URAT1) inhibitor for gout and potentially other hyperuricemic indications including chronic kidney
Fortress Bio: Interesting Model Of Doing Medicine
07:19am, Thursday, 29'th Apr 2021
Fortress Bio: Interesting Model Of Doing Medicine
3 Penny Stocks That Wall Street Wants You To Buy Now
02:51pm, Wednesday, 21'st Apr 2021
Penny stocks are very risky, which is why they have such low prices. Many of the companies in this risky part of the market will go bankrupt.